Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 171, Issue 6, 2005, Pages 587-590

  Teper, Alejandro M ^a   Kofman, Carlos D ^a   Szulman, Gabriela A ^a   Vidaurreta, Santiago M ^a   Maffey, Alberto F ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Asthma; Infants; Inhaled corticosteroids; Pulmonary function

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL;

ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EMERGENCY TREATMENT; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; LONG TERM CARE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOM; WHEEZING;

ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; MALE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SOUNDS; RISK FACTORS; TIME FACTORS;

EID: 14944383626     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200408-1088OC     Document Type: Article

References (34)

1. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138.
2. Martinez FD, Morgan WJ, Wright AL, Holberg CJ, Taussig LM. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988;319:1112-1117.
3. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999;354:541-545.
4. Dodge R, Martinez FD, Cline MG, Lebowitz MD, Burrows B. Early childhood respiratory symptoms and subsequent diagnosis of asthma. J Allergy Clin Immunol 1996;98:48-54.
5. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-1406.
6. National Institutes of Health. Global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health National Heart, Lung, and Blood Institute; 2002 (revised). Revised 2002. NIH Publication No. 02-3659.
7. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-381.
8. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children. A dose comparison study. Am J Respir Crit Care Med 1999;160:126-131.
9. Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergada I. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatr Pulmonol 2004;37:111-115.
10. Mellon M, for the Budesonide Inhalation Suspension Study Group. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 1999;104:S191-S199.
11. de Benedictis FM, Martinati LC, Solinas LF, Tuteri G, Boner AL. Nebulized flunisolide in infants and young children with asthma: a pilot study. Pediatr Pulmonol 1996;21:310-315.
12. Devulapalli CS, Haaland G, Pettersen M, Carlsen KH, Lodrup Carlsen KC. Effect of inhaled steroids on lung function in young children: a cohort study. Eur Respir J 2004;23:869-875.
13. Moeller A, Franklin P, Hall GL, Turner S, Straub D, Wildhaber JH, Stick SM. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrently wheezy infants. Pediatr Pulmonol 2004;38:250-255.
14. Teper AM, Szulman GA, Kofman CD, Navarra F, Zaragoza S, Fernandez S, Molise MC, Maffey AF, Vidaurreta SM. Does fluticasone propionate (FP) improve pulmonary function in asthmatic infants [abstract]? Eur Respir J 2003;22:A3108.
15. Taussig LM, Landau LI, Godfrey S, Arad I. Determinants of forced expiratory flows in newborn infants. J Appl Physiol 1982;53:1220-1227.
16. Sly PD, Tepper R, Henschen M, Gappa M, Stocks J. Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J 2000;16:741-748.
17. Koumbourlis AC, Chen XC, Rao JS, Schlucter MD, Easley K, Colin AA, Hiatt P, Kattan M, McCarthy K, Mellins RB, et al. Maximal expiratory flow at FRC (VmaxFRC): methods of selection and differences in reported values. Pediatr Pulmonol 2004;37:318-323.
18. Hoo AF, Dezateux C, Hanrahan JP, Cole TJ, Tepper RS, Stocks J. Sex-specific prediction equations for VmaxFRC in infancy. A multicenter collaborative study. Am J Respir Crit Care Med 2002;165:1084-1092.
19. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Illness Study Group. Am Rev Respir Dis 1992;46:547-554.
20. Hoekstra MO, Grol MH, Bouman K, Stijnen T, Koeter GH, Kauffman HF, Gerritsen J. Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med 1996;154:1039-1044.
21. Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol 1997;78:356-362.
22. Pao CS, McKenzie SA. Randomized controlled trial of fluticasone on preschool children with intermittent wheeze. Am J Respir Crit Care Med 2002;166:945-949.
23. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5- year-old asthmatic children. Am J Respir Crit Care Med 2000;162: 1500-1506.
24. Furfaro S, Spier S, Drbik SP, Turgeon JP, Robert M. Efficacy of cromglycate in persistently wheezing infants. Arch Dis Child 1994;71:331-334.
25. Tasche MJ, Uijen JH, Bernsen RM, de Jongste JC, van der Wouden JC. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 2000;55:913-920.
26. Wildhaber JH, Doreb ND, Devadason SG, Hall GL, Hamacher J, Arheden L, LeSouëf PN. Comparison of subjective and objective measures in recurrently wheezy infants. Respiration (Herrlisheim) 2002;69:397-405.
27. Lowe L, Murray CS, Martin L, Deas J, Cashin E, Poletti G, Simpson A, Woodcock A, Custovic A. Reported versus confirmed wheeze and lung function in early life. Arch Dis Child 2004;89:540-543.
28. Stick SM, Burton PR, Clough JB, Cox M, LeSouef PN, Sly PD. The effects of inhaled bedomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch Dis Child 1995;73:327-332.
29. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, Jeffery PK. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;167:78-82.
30. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen Y, Ohlsson SV, Ullman A, Lamm CJ, O'Byrne PM on behalf of the START investigators group. Early intervention with budesonide in mild persistent asthma: a randomized, double-blind trial. Lancet 2003;361:1071-1076.
31. Tager IB, Hanrahan JP, Tosteson TD, Castile RG, Brown RW, Weiss ST, Speizer FE. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life. Am Rev Respir Dis 1993;147:811-817.
32. Young S, Le Souef PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med 1991;324:1168.
33. Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RG, Van Vunakis H, Weiss ST, Speizer FE. The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis 1992;145:1129-1135.
34. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Pediatr 1998;132:472-477.